2026-10-12T13:00:44Z https://api.figshare.com/v2/oai

oai:figshare.com:article/33994425 2026-09-25T10:00:13Z category_37339 category_37360 category_37366 category_37375 portal_1012 item_type_3 month_year_09_2026

Supplementary Table S1 from SHIVA02 Trial: Using Patients as Their Own Controls to Assess Efficacy of Therapies Based on Molecular Profiling in Patients with Refractory Cancer Pauline du Rusquec (25109214) Célia Dupain (20147229) Romain Geiss (25109217) Marie-Paule Sablin (17977717) Zahra Castel-Ajgal (25109220) Philippe Cassier (25109223) Antoine Italiano (15054013) Edith Borcoman (25109226) Jerzy Klijanienko (25109229) Vincent Servois (25109232) Laurence Raizonville (25109235) Fanny Coffin (25109238) Julien Romejon (25109241) Philippe Hupé (25109244) Laëtitia Chanas (25109247) Sylvain Dureau (22847296) Eleonore Frouin (25109250) Odette Mariani (15015551) Samantha Antonio (25109253) Céline Callens (25109256) Samia Melaabi (25109259) Julien Masliah-Planchon (19275659) Elodie Girard (25109262) Nicolas Servant (25109265) Maud Kamal (20972004) Ivan Bièche (20972010) Xavier Paoletti (17977427) Christophe Le Tourneau (15024530) Cancer Therapeutic Research and Development Clinical Research and Trials Methods and Technology Biostatistics Survival analysis Clinical Trial Results Clinical trials in minorities & underserved populations Drug Targets Precision Medicine <p>Detailed characteristics of patients evaluable for the PFS ratio</p> 2026-09-25T00:00:00Z Dataset Dataset 10.1158/2767-9764.33994425 https://figshare.com/articles/dataset/Supplementary_Table_S1_from_SHIVA02_Trial_Using_Patients_as_Their_Own_Controls_to_Assess_Efficacy_of_Therapies_Based_on_Molecular_Profiling_in_Patients_with_Refractory_Cancer/33994425 CC BY